Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
30,457,133
-
Share change
-
+15,983,432
-
Total reported value
-
$1,093,469,744
-
Put/Call ratio
-
183%
-
Price per share
-
$35.92
-
Number of holders
-
144
-
Value change
-
+$554,881,018
-
Number of buys
-
136
-
Number of sells
-
25
Institutional Holders of INSYS THERAPEUTICS INC NEW - COM NEW (INSYQ) as of Q2 2015
As of 30 Jun 2015 INSYS THERAPEUTICS INC NEW - COM NEW (INSYQ) had 144 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 30,457,133 shares of stock of the company.
Largest 10 holders included JANUS CAPITAL MANAGEMENT LLC, Consonance Capital Management LP, ORBIMED ADVISORS LLC, FMR LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, STATE STREET CORP, Invesco Ltd., SCOPIA CAPITAL MANAGEMENT LP, and LOOMIS SAYLES & CO L P.
This table shows 144 institutional shareholders of the security as of 30 Jun 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.